SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Schumacher HR. Synovial inflammation, crystals and osteoarthritis. J Rheumatol 1995; 22 Suppl 43: 1013.
  • 2
    Jean-Pierre Pelletier, Martell-Pelletier J, Howel DS. Etiopathogenesis of osteoarthritis. In: KoopmanWJ, editor. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Philadelphia: Williams & Wilkins; 1997. p. 196984.
  • 3
    Gibilisco PA, Schumacher HR Jr, Hollander JL, Soper KA. Synovial fluid crystals in osteoarthritis. Arthritis Rheum 1985; 28: 5115.
  • 4
    Halverson P, McCarty D. Patterns of radiographic abnormalities associated with basic calcium phosphate and calcium pyrophosphate dihydrate crystal deposition in the knee. Ann Rheum Dis 1986; 45: 6035.
  • 5
    Alvarellos A, Spilberg I. Colchicine prophylaxis in pseudogout. J Rheumatol 1986; 13: 8045.
  • 6
    Das SK, Chandra A, Sahani K, Sircar AR. A preliminary clinical trial to assess short term symptom modifying effect of a regimen containing colchicine in a selected subset of patients with osteoarthritis knee. J Indian Rheumatism Association 1999; 7: 811.
  • 7
    Swan A, Chapman B, Heap P, Seward H, Dieppe P. Submicroscopic crystals in osteoarthritic synovial fluids. Ann Rheum Dis 1994; 53: 46770.
  • 8
    Reitz DS, Li JL, Norton MB, Reinhard EJ, Collins JT, Anderson GD, et al. Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors. J Med Chem 1994; 37: 387881.
  • 9
    Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the Knee. Arthritis Rheum 1986; 29: 103949.
  • 10
    Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 183340.
  • 11
    Altman RD, Hochberg M, Murphy WA, Wolfe F, Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cart 1995; 3: 370.
  • 12
    Roth SH. Efficacy and safety of tramadol HC1 in breakthrough musculoskeletal pain attributed to osteoarthritis. J Rheumatol 1998; 25: 5863.
  • 13
    Doyle DV, Dieppe PA, Scott J, Huskisson EC. An articular index for the assessment of osteoarthritis. Ann Rheum Dis 1981; 40: 758.
  • 14
    Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 15
    Ravaud P, Moulinier L, Giraudeau B, Ayral X, Guerin C, Noel E, et al. Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum 1999; 42: 47582.
  • 16
    Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum 1998; 28: 4859.
  • 17
    Ryan LM, Cheung HS. The role of crystals in osteoarthritis. Rheumatic Dis Clin North Am 1999; 25: 25767.
  • 18
    Honig EG, Ingram RH. Chronic bronchitis, emphysema, and airway obstruction. In: FauciAS, BraunwaldE, IsselbacherKJ, WilsonJD, MartinJB, KasperDL, et al, editors. Harrison's principles of internal medicine. 14th ed. International edition: McGraw-Hill; 1998. p. 145160.